Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Newspaper/Magazine Article

FDA Advise-ERR: reported medication errors with Veklury (remdesivir) emergency use authorization.

FDA Advise-ERR: reported medication errors with Veklury (remdesivir) emergency use authorization. ISMP Medication Safety Alert! Acute care edition. September 10, 2020;25(18)

Save
Print
September 23, 2020

ISMP Medication Safety Alert! Acute care edition. September 10, 2020;25(18)

This alert discusses medication errors that have been reported to the Food and Drug Administration involving the preparation, administration, and storage of two formulations of the investigational COVID-19 treatment remdesivir. Recommendations to guide safe practice include use of standard order sets and dosing clarifications.

Save
Print
Cite
Citation

FDA Advise-ERR: reported medication errors with Veklury (remdesivir) emergency use authorization. ISMP Medication Safety Alert! Acute care edition. September 10, 2020;25(18)